Tianjin Third Central Hospital

This study looks at whether a special ultrasound using a contrast agent called Sonazoid can find early-stage liver cancer better than a regular ultrasound. About 556 adults with liver cirrhosis will be monitored every 4 to 6 months with both methods. The goal is to see if Sonazoi…